ESCRT ‐ III Subunit CHMP4C Regulates Angiogenesis by Targeting Endocytic Trafficking of GSK3β
The FASEB Journal · 2025
DOI: 10.1096/fj.202500639rrrr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Wen Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Endosomal Sorting Complexes Required for Transport, Glycogen Synthase Kinase 3 beta, Ischemia, Neovascularization, Physiologic. Die Arbeit nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC), Shanghai Municipal Health Commission, STCSM | Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
Angiogenesis is critical for tissue repair in chronic ischemia. Chromatin modified protein 4C (CHMP4C), a subunit of the endosomal sorting complex required for transport ‐III (ESCRT‐III), is involved in endocytic progress and cell proliferation. Recent evidence suggests ESCRT‐III plays a vital role in endothelial function. This study aimed to determine the role of endothelial CHMP4C in angiogenesis, as well as the underlying molecular mechanisms. Hind‐limb ischemia (HLI) was surgically induced in both CHMP4C −/− mice and wild‐type C57BL/6J mice. Loss of CHMP4C was associated with significant decreases in blood perfusion and post‐ischemia capillary density. In vitro, knockdown of CHMP4C by small interfering RNAs (siRNAs) impaired the angiogenic and proliferative functions of endothelial cells (ECs) and induced G1/S cell cycle arrest under hypoxic conditions. RNA‐Seq data and further analysis revealed repression of the Wnt/β‐catenin pathway and hyperactivation of GSK3β in CHMP4C‐deficiency ECs. Selective inhibition of GSK3β significantly ameliorated the inhibitory effects of CHMP4C deficiency on the Wnt/β‐catenin pathway and proliferative functions in vitro. Electron microscopy and immunohistochemical colocalization analysis further revealed that CHMP4C deficiency impedes endocytic trafficking of GSK3β. Overall, these findings reveal that CHMP4C regulates angiogenesis by modulating endocytic trafficking of GSK3β, indentifying it as a potential therapeutic target for ischemic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
- Shanghai Institute of Medical Imaging, Fudan University, Shanghai, China.
- Reproductive Medicine Centre, Zhongshan Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Wen Liu, Xianhong Shu
Förderung
- National Natural Science Foundation of China (NSFC)
- Shanghai Municipal Health Commission
- STCSM | Natural Science Foundation of Shanghai
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Liu, W., Ding, S., Zhang, Z., Zhou, N., Weng, H., Xie, H., Tian, F., Liu, A., Wei, X., Xu, N., Yang, X., & Shu, X. (2025). ESCRT ‐ III Subunit CHMP4C Regulates Angiogenesis by Targeting Endocytic Trafficking of GSK3β. The FASEB Journal. https://doi.org/10.1096/fj.202500639rrrr
Vancouver
Liu W, Ding S, Zhang Z, Zhou N, Weng H, Xie H, et al. ESCRT ‐ III Subunit CHMP4C Regulates Angiogenesis by Targeting Endocytic Trafficking of GSK3β. The FASEB Journal. 2025. doi:10.1096/fj.202500639rrrr
BibTeX
@article{Liu2025,
author = {Liu, Wen and Ding, Suling and Zhang, Zhiwei and Zhou, Nianwei and Weng, Haobo and Xie, Huilin and Tian, Fangyan and Liu, Ao and Wei, Xuemei and Xu, Nuo and Yang, Xiangdong and Shu, Xianhong},
title = {ESCRT ‐ III Subunit CHMP4C Regulates Angiogenesis by Targeting Endocytic Trafficking of GSK3β},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202500639rrrr}
}
EUVIMED